Lupin recalls over 23,000 bottles of antibiotic drug in US

09 Jan 2019 Evaluate

Lupin is recalling over 23,000 bottles of an antibiotic drug in the US for being sub-potent. The company is recalling the lot due to below specification results for assay.

As per the latest Enforcement Report issued by the US Food and Drug Administration (USFDA), Lupin Somerset is recalling 23,460 bottles of Nitrofurantoin oral suspension which is used to treat or prevent certain bladder infections.

Lupin is an innovation led transnational pharmaceutical company developing and delivering a wide range of branded & generic formulations, biotechnology products and APIs globally.

Lupin Share Price

2296.15 2.60 (0.11%)
09-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1717.35
Dr. Reddys Lab 1212.35
Cipla 1224.25
Zydus Lifesciences 902.15
Lupin 2296.15
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×